Edaravone, a novel free radical scavenger, prevents steroid-induced osteonecrosis in rabbits

Rheumatology (United Kingdom)

Volumn 52, Issue 3, 2013, Pages 438-447

  Li, Guang Yi ^a   Feng, Yong ^a   Cheng, Tak S ^b   Yin, Ji Min ^a   Zhang, Chang Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

DNA damage; Edaravone; Lipid peroxidation; Oxidative stress; Steroid induced osteonecrosis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUTATHIONE; MALONALDEHYDE; METHYLPREDNISOLONE; NORPHENAZONE; SCAVENGER; SIMCERE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BONE NECROSIS; BONE TISSUE; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MICROANGIOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT;

ANIMALS; ANTIPYRINE; DNA DAMAGE; FREE RADICAL SCAVENGERS; GLUCOCORTICOIDS; GLUTATHIONE; LIPID PEROXIDATION; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; OXIDATIVE STRESS; RABBITS; TREATMENT OUTCOME;

EID: 84874054350     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes313     Document Type: Article

References (43)

1. Nagasawa K, Tada Y, Koarada S et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005;14:385-90.
2. Bragge P, Chau M, Pitt VJ et al. An overview of published research about the acute care and rehabilitation of traumatic brain injured and spinal cord injured patients. J Neurotrauma 2012;29:1539-47.
3. Ingvar A, Smedby KE, Lindelöf B et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2010; 25:2764-71.
4. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995; 77:459-74.
5. Lieberman JR, Berry DJ, Mont MA et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2002;52:337-55.
6. Glueck CJ, Freiberg RA, Fontaine RN. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 2001; 386:19-33.
7. Miyanishi K, Yamamoto T, Irisa T et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 2002;30: 185-90.
8. Boss JH, Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 2003;40: 345-54.
9. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
10. Gobbo MG, Ribeiro DL, Taboga SR, de Almeida EA, Gó es RM. Oxidative stress markers and apoptosis in the prostate of diabetic rats and the influence of vitamin C treatment. J Cell Biochem 2012;113:2223-33.
11. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S. Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 2004; 9:509-15.
12. Ichiseki T, Ueda Y, Katsuda S et al. Oxidative stress by glutathione depletion induces osteonecrosis in rats. Rheumatology 2006;45:287-90.
13. Kuribayashi M, Fujioka M, Takahashi KA et al. Vitamin E prevents steroid-induced osteonecrosis in rabbits. Acta Orthop 2010;81:154-60.
14. Miyata N, Kumagai K, Osaki M et al. Pentosan reduces osteonecrosis of femoral head in SHRSP. Clin Exp Hypertens 2010;32:511-6.
15. Iuchi T, Akaike M, Mitsui T et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003;92:81-7.
16. Watanabe T, Tahara M, Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther 2008; 26:101-14.
17. Higashi Y, Jitsuiki D, Chayama K, Yoshizumi M. Edaravone (3-methyl-1-phenyl-2-pyrazolin -5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2006; 1:85-93.
18. Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006;12:9-20.
19. Ichiseki T, Kaneuji A, Katsuda S et al. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology 2005;44:456-60.
20. Mikami T, Ichiseki T, Kaneuji A et al. Prevention of steroid-induced osteonecrosis by intravenous administration of vitamin E in a rabbit model. J Orthop Sci 2010; 15:674-7.
21. Sun Y, Feng Y, Zhang C. The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 2009;76:685-90.
22. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997;40:2055-64.
23. Lu BB, Li KH. Lipoic acid prevents steroid-induced osteonecrosis in rabbits. Rheumatol Int 2012;32:1679-83.
24. Nozaki Y, Kumagai K, Miyata N, Niwa M. Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats. Acta Orthop 2012;83:87-92.
25. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Séguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 2006;13:237-44.
26. Kabata T, Kubo T, Matsumoto T et al. Apoptotic cell death in steroid induced osteonecrosis: an experimental study in rabbits. J Rheumatol 2000;27:2166-71.
27. Watanabe T, Yuki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994;268:1597-604.
28. Yagi H, Horinaka S, Matsuoka H. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat. J Cardiovasc Pharmacol 2005;46:46-51.
29. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007;113:234-58.
30. Sasaguri Y, Nakashima T, Morimatsu M, Yagi K. Injury to cultured endothelial cells from human umbilical vein by linoleic acid hydroperoxide. J Appl Biochem 1984;6: 144-50.
31. Hansen-Hagge TE, Baumeister E, Bauer T et al. Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress. Atherosclerosis 2008; 197:602-11.
32. La E, Kern JC, Atarod EB, Kehrer JP. Fatty acid release and oxidation are factors in lipoxygenase inhibitorinduced apoptosis. Toxicol Lett 2003;138:193-203.
33. Atsumi T, Kuroki Y. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 1992;277: 22-30.
34. Zhang G, Qin L, Sheng H et al. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone 2009;44:345-56.
35. Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM. Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res 1978;16:369-72.
36. Jacobs B. Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 1978;130:51-67.
37. Starklint H, Lausten GS, Arnoldi CC. Microvascular obstruction in avascular necrosis. Immunohistochemistry of 14 femoral heads. Acta Orthop Scand 1995;66:9-12.
38. Schilling WP, Elliott SJ. Ca2+ signaling mechanisms of vascular endothelial cells and their role in oxidant-induced endothelial cell dysfunction. Am J Physiol 1992; 262(6 Pt 2):H1617-30.
39. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365-74.
40. Ramos VA, Ramos PA, Dominguez MC. The role of oxidative stress in inflammation in patients with juvenile rheumatoid arthritis. J Pediatr 2000;76:125-32.
41. Xi H, Akishita M, Nagai K et al. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis. Atherosclerosis 2007;191:281-9.
42. Ozgiray E, Serarslan Y, Oztürk OH et al. Protective effects of edaravone on experimental spinal cord injury in rats. Pediatr Neurosurg 2011;47:254-60.
43. Jones JP Jr. Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res 1993;292: 294-308.